Most random gene expression signatures are significantly associated with breast cancer outcome.

by David Venet, Jacques E Dumont, Vincent Detours
Published 2011-10-01

Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications

by Valerie Jacquemin, Mathieu Antoine, Geneviève Dom, Vincent Detours, Carine Maenhaut, Jacques E. Dumont
Published 2022-01-01

Profiling of olfactory receptor gene expression in whole human olfactory mucosa.

by Christophe Verbeurgt, Françoise Wilkin, Maxime Tarabichi, Françoise Gregoire, Jacques E Dumont, Pierre Chatelain
Published 2014-01-01

Transcriptomic Signature of Human Embryonic Thyroid Reveals Transition From Differentiation to Functional Maturation

by Geneviève Dom, Geneviève Dom, Petr Dmitriev, Petr Dmitriev, Marie-Alexandra Lambot, Guy Van Vliet, Guy Van Vliet, Daniel Glinoer, Frédérick Libert, Anne Lefort, Jacques E. Dumont, Jacques E. Dumont, Carine Maenhaut, Carine Maenhaut
Published 2021-06-01

The human bitter taste receptor T2R38 is broadly tuned for bacterial compounds.

by Christophe Verbeurgt, Alex Veithen, Sébastien Carlot, Maxime Tarabichi, Jacques E Dumont, Sergio Hassid, Pierre Chatelain
Published 2017-01-01

mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch.

by Aline Hébrant, Geneviève Dom, Michael Dewaele, Guy Andry, Christophe Trésallet, Emmanuelle Leteurtre, Jacques E Dumont, Carine Maenhaut
Published 2012-01-01

Commentary: Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture

by Aglaia Kyrilli, Aglaia Kyrilli, Sabine Paternot, Françoise Miot, Bernard Corvilain, Bernard Corvilain, Gilbert Vassart, Pierre P. Roger, Jacques E. Dumont
Published 2017-08-01

MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models.

by Sébastien L Floor, Aline Hebrant, Jaime M Pita, Manuel Saiselet, Christophe Trésallet, Frederick Libert, Guy Andry, Jacques E Dumont, Wilma C van Staveren, Carine Maenhaut
Published 2014-01-01

CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas

by Jaime M. Pita, Eric Raspé, Katia Coulonval, Myriam Decaussin-Petrucci, Maxime Tarabichi, Geneviève Dom, Frederick Libert, Frederick Libert, Ligia Craciun, Guy Andry, Laurence Wicquart, Emmanuelle Leteurtre, Christophe Trésallet, Christophe Trésallet, Laura A. Marlow, John A. Copland, Cosimo Durante, Carine Maenhaut, Branca M. Cavaco, Jacques E. Dumont, Giuseppe Costante, Pierre P. Roger
Published 2023-10-01